Epirus Biopharmaceuticals Investors

20 investors on Angel Roster list Epirus Biopharmaceuticals in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Epirus Biopharmaceuticals can appear together.

Investors listed
20
With verified email
40%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 20 Epirus Biopharmaceuticals investors

The most complete profiles first. Showing 20 of 20.

  • Andy SchwabVerified

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 57 more

    Verified email available

  • Brian DanielsVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Deborah PalestrantVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Jason RuthVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Lou TartagliaVerified

    Venture Capital, Founder, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more

    Verified email available

  • Rebecca ChenVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Dan TurnerVerified

    Venture Capital, Private Equity Firm, Micro VC · United States

    Health CareHospitalsE-commerceCybersecurity

    Portfolio: Novalar Pharmaceuticals, StorageWay, Colorescience, Transcept Pharmaceuticals and 35 more

    Verified email available

  • Elliot EhrichVerified

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Jonathan WeissmanVerified

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Paul StoneVerified

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Jamil M. Beg

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • John Diekman

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more

    Contact details available

  • Mason Freeman

    Venture Capital, Investor · United States

    SeedHealth CareHospitalsGeneticsLife Science

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Michael Matly

    Venture Capital, Private Equity Firm, Micro VC · United States

    SeedHealth CareHospitalsE-commerceCybersecurity

    Portfolio: Novalar Pharmaceuticals, Mindbody Business, StorageWay, Colorescience and 36 more

    Contact details available

  • Mira Chaurushiya

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsAlternative MedicineAndroid

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Scott Rocklage

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more

    Contact details available

  • Eran Nadav

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Genoa Pharmaceuticals, Enlibrium, CardioDx, Alphabet Energy and 31 more

    Contact details available

  • Jessica Hou

    Micro VC · United States

    Health CareHospitalsE-commerceCybersecurity

    Portfolio: Novalar Pharmaceuticals, StorageWay, Colorescience, Transcept Pharmaceuticals and 35 more

    Contact details available

  • Joseph Victor

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Peter Kim

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

Frequently asked questions

How many Epirus Biopharmaceuticals investors are on Angel Roster?

Angel Roster lists 20 Epirus Biopharmaceuticals investors. 8 of them (40%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (19), Private Equity Firms (10) and Founder-Investors (4). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Epirus Biopharmaceuticals investors invest in?

Among those that list a stage, the most common are Seed (12).

Where are Epirus Biopharmaceuticals investors based?

Most are based in the United States (20).

Which companies have Epirus Biopharmaceuticals investors backed?

The most-backed portfolio companies among them are Wildcat Discovery Technologies (16), Scientist.com (16), Ensoma (16), Vor Biopharma (16) and TMRW Life Sciences (16).

How do I contact Epirus Biopharmaceuticals investors?

Create a free Angel Roster account to search and filter all 20, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.